Lexeo Therapeutics Inc (LXEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 0 | 0 | 0 | 0 | 531 |
| Gross Profit | N/A | N/A | N/A | N/A | 531 |
| Operating Expenses | 20,273 | 13,975 | 19,290 | 0 | 18,013 |
| Operating Income | -20,273 | -13,975 | -19,290 | N/A | -17,482 |
| Interest Expense | 52 | 53 | 50 | 0 | 29 |
| Other Income | 217 | 587 | 683 | 0 | 456 |
| Pre-tax Income | -20,108 | -13,441 | -18,657 | 0 | -17,055 |
| Net Income Continuous | -20,108 | -13,441 | -18,657 | N/A | -17,055 |
| Net Income | $-20,108 | $-13,441 | $-18,657 | $N/A | $-17,055 |
| EPS Basic Total Ops | -12.36 | -8.30 | -11.58 | N/A | -10.38 |
| EPS Basic Continuous Ops | -12.36 | -8.30 | -11.58 | N/A | -10.38 |
| EPS Diluted Total Ops | -12.36 | -8.30 | -11.58 | N/A | -10.38 |
| EPS Diluted Continuous Ops | -12.36 | -8.30 | -11.58 | N/A | -10.38 |
| EBITDA(a) | $-20,195 | $-14,306 | $-18,843 | $N/A | $-17,482 |